Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy

The Journal of Urology
Anthony CookAntoine Khoury

Abstract

RCC represents less than 2% to 6% of pediatric renal tumors. Few reports of long-term outcomes exist. We sought to determine the presentation, treatment and outcome of patients at our institution. We retrospectively reviewed the age, mode of presentation, mode of treatment, histological subtype, tumor grade, stage and survival of all patients with RCC from 1980 to 2005. A total of 15 patients were identified. Mean age at presentation was 7.9 years. Symptomatic presentations in nearly 75% of patients included gross hematuria, abdominal pain and polycythemia. The remaining 25% of cases were asymptomatic, and were identified by physical examination or incidentally on imaging. Surgical resection consisted of radical nephrectomy in 10 patients and partial nephrectomy in 5. Pathological analysis revealed papillary RCC in 8 patients and clear cell RCC in 7. Six patients had high stage disease. One patient with stage IV disease died 8 months postoperatively. The remaining 14 patients were alive at a mean followup of 4.9 years. All but 1 patient remain recurrence-free, including all of those who underwent nephron sparing surgery. To our knowledge this single institution series is the first to include children treated with partial nephre...Continue Reading

References

Mar 1, 1979·Urology·L P SusanR A Straffon
Oct 1, 1982·The American Journal of Surgical Pathology·S A FuhrmanC Limas
Aug 1, 1995·Urology·A C Novick
Sep 2, 1998·Medical and Pediatric Oncology·M D CarcaoS Baruchel
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BelldegrunR B Smith
Jan 5, 2002·The New England Journal of Medicine·A J PantuckR A Figlin
Feb 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo IndolfiM Teresa Di Tullio
Sep 5, 2003·The Urologic Clinics of North America·Alan M Nieder, Samir S Taneja

❮ Previous
Next ❯

Citations

Jan 18, 2012·Pediatric Radiology·Ryan T DowneyPeter J Strouse
Mar 3, 2007·Pediatric Surgery International·Apostolos P LabanarisVahudin Zugor
Feb 13, 2014·Journal of Pediatric Urology·David I ChuJonathan C Routh
Mar 1, 2012·Journal of Pediatric Hematology/oncology·Bahar AkkayaVolkan Hazar
Oct 22, 2008·Pediatric Blood & Cancer·Jonathan SilbersteinChristopher J Kane
Apr 5, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·B FallB-A Diagne
May 27, 2008·Urology·Manuel BosquetFernando García-Ibarra
Nov 3, 2016·Pediatric Blood & Cancer·Jamil S SyedBrian Shuch
Dec 17, 2009·Journal of Pediatric Surgery·Katsumi KadekawaKimio Sugaya
May 16, 2009·Journal of Pediatric Urology·Justin E SausvilleJohn P Gearhart
Dec 19, 2016·Bulletin du cancer·Brice FresneauCharlotte Demoor-Goldschmidt
May 2, 2017·Rare Tumors·Prajwal DhakalVijaya Raj Bhatt
Dec 3, 2014·The Journal of Urology·Ardavan AkhavanPaul A Merguerian
Dec 7, 2006·Virchows Archiv : an International Journal of Pathology·Chi-Kuan ChenJim-Ray Chen
Jul 6, 2007·Pathology International·Kunihiko YoshiokaMasaaki Tachibana
Jul 1, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Minki BaekDong Soo Ryu
Jul 2, 2019·Current Opinion in Urology·Kiersten M CraigArdavan Akhavan
Nov 19, 2019·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Wai Chin Chong, Jason E Cain
Mar 15, 2016·The American Journal of Surgical Pathology·Sara M FalzaranoCristina Magi-Galluzzi
Jul 9, 2020·Cancers·Justine N van der BeekMarry M van den Heuvel-Eibrink
Sep 2, 2020·Pediatric Blood & Cancer·Satyajit RayDermot Murphy
Nov 30, 2010·Expert Review of Anticancer Therapy·Filippo SpreaficoLuigi Piva
Jun 11, 2017·Der Urologe. Ausg. A·L WeisbachS Riechardt
Apr 7, 2010·Pediatric Hematology and Oncology·Vural KesikMünevver Büyükpamukçu
May 7, 2015·International Cancer Conference Journal·Ko OkabeNaoya Masumori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.